Literature DB >> 30188508

Sarcomere gene variants act as a genetic trigger underlying the development of left ventricular noncompaction.

Asami Takasaki1, Keiichi Hirono1, Yukiko Hata2, Ce Wang1,3, Masafumi Takeda4, Jun K Yamashita4, Bo Chang1, Hideyuki Nakaoka1, Mako Okabe1, Nariaki Miyao1, Kazuyoshi Saito1, Keijiro Ibuki1, Sayaka Ozawa1, Michikazu Sekine5, Naoki Yoshimura6, Naoki Nishida2, Neil E Bowles7, Fukiko Ichida8.   

Abstract

BACKGROUND: Left ventricular noncompaction (LVNC) is a primary cardiomyopathy with heterogeneous genetic origins. The aim of this study was to elucidate the role of sarcomere gene variants in the pathogenesis and prognosis of LVNC. METHODS AND
RESULTS: We screened 82 Japanese patients (0-35 years old), with a diagnosis of LVNC, for mutations in seven genes encoding sarcomere proteins, by direct DNA sequencing. We identified variants in a significant proportion of cases (27%), which were associated with poor prognosis (p = 0.012), particularly variants in TPM1, TNNC1, and ACTC1 (p = 0.012). To elucidate the pathological role, we developed and studied human-induced pluripotent stem cells (hiPSCs) from a patient carrying a TPM1 p.Arg178His mutation, who underwent heart transplantation. These cells displayed pathological changes, with mislocalization of tropomyosin 1, causing disruption of the sarcomere structure in cardiomyocytes, and impaired calcium handling. Microarray analysis indicated that the TPM1 mutation resulted in the down-regulation of the expression of numerous genes involved in heart development, and positive regulation of cellular process, especially the calcium signaling pathway.
CONCLUSIONS: Sarcomere genes are implicated as genetic triggers in the development of LVNC, regulating the expression of numerous genes involved in heart development, or modifying the severity of disease.

Entities:  

Mesh:

Year:  2018        PMID: 30188508     DOI: 10.1038/s41390-018-0162-1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

Review 1.  Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.

Authors:  Tarek Khedro; Jason M Duran; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2022-06-03       Impact factor: 3.955

Review 2.  Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy.

Authors:  Josè Manuel Pioner; Alessandra Fornaro; Raffaele Coppini; Nicole Ceschia; Leonardo Sacconi; Maria Alice Donati; Silvia Favilli; Corrado Poggesi; Iacopo Olivotto; Cecilia Ferrantini
Journal:  Front Physiol       Date:  2020-05-12       Impact factor: 4.566

3.  Mutations in RNA Methyltransferase Gene NSUN5 Confer High Risk of Outflow Tract Malformation.

Authors:  Yifeng Wang; Tao Jiang; Jiani Xu; Yayun Gu; Yan Zhou; Yuan Lin; Yifei Wu; Wei Li; Cheng Wang; Bin Shen; Xuming Mo; Xiaowei Wang; Bin Zhou; Chenyue Ding; Zhibin Hu
Journal:  Front Cell Dev Biol       Date:  2021-04-21

4.  Overlap phenotypes of the left ventricular noncompaction and hypertrophic cardiomyopathy with complex arrhythmias and heart failure induced by the novel truncated DSC2 mutation.

Authors:  Yubi Lin; Jiana Huang; Zhiling Zhu; Zuoquan Zhang; Jianzhong Xian; Zhe Yang; Tingfeng Qin; Linxi Chen; Jingmin Huang; Yin Huang; Qiaoyun Wu; Zhenyu Hu; Xiufang Lin; Geyang Xu
Journal:  Orphanet J Rare Dis       Date:  2021-11-24       Impact factor: 4.123

5.  Genetic Profile of Left Ventricular Noncompaction Cardiomyopathy in Children-A Single Reference Center Experience.

Authors:  Dorota Piekutowska-Abramczuk; Agata Paszkowska; Elżbieta Ciara; Kamila Frączak; Alicja Mirecka-Rola; Dorota Wicher; Agnieszka Pollak; Karolina Rutkowska; Jędrzej Sarnecki; Lidia Ziółkowska
Journal:  Genes (Basel)       Date:  2022-07-26       Impact factor: 4.141

6.  Different Phenotypes of Sarcomeric MyBPC3-Cardiomyopathy in the Same Family: Hypertrophic, Left Ventricular Noncompaction and Restrictive Phenotypes (in Association with Sarcoidosis).

Authors:  Olga Blagova; Ekaterina Pavlenko; Vsevolod Sedov; Evgeniya Kogan; Margarita Polyak; Elena Zaklyazminskaya; Yulia Lutokhina
Journal:  Genes (Basel)       Date:  2022-07-27       Impact factor: 4.141

Review 7.  Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells.

Authors:  Xue Jiang; Yihuan Chen; Xiaofeng Liu; Lingqun Ye; Miao Yu; Zhenya Shen; Wei Lei; Shijun Hu
Journal:  Front Cell Dev Biol       Date:  2021-05-17

8.  Elevated myocardial SORBS2 and the underlying implications in left ventricular noncompaction cardiomyopathy.

Authors:  Chunyan Li; Fan Liu; Shenghua Liu; Haizhou Pan; Haiwei Du; Jian Huang; Yuanyuan Xie; Yanfen Li; Ranxu Zhao; Yingjie Wei
Journal:  EBioMedicine       Date:  2020-03-03       Impact factor: 8.143

9.  The Use of Induced Pluripotent Stem Cells as a Model for Developmental Eye Disorders.

Authors:  Jonathan Eintracht; Maria Toms; Mariya Moosajee
Journal:  Front Cell Neurosci       Date:  2020-08-20       Impact factor: 5.505

10.  A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C.

Authors:  Tyler R Reinoso; Maicon Landim-Vieira; Yun Shi; Jamie R Johnston; P Bryant Chase; Michelle S Parvatiyar; Andrew P Landstrom; Jose R Pinto; Hanna J Tadros
Journal:  J Muscle Res Cell Motil       Date:  2020-11-11       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.